Company Overview

BBy, formerly known as BBy, Inc, operates in the healthcare industry, focusing on medical devices. Headquartered in New York, NY, USA, BBy has a team of 7 employees. The company is renowned for its innovative solutions in breast milk processing, including a condensing device that turns milk into a fine powder while preserving its biological and immunological activity. BBy launched in February 2022 and participated in Y Combinator's W22 batch. Their technology eliminates the need for freezing and defrosting in infant milk preparation, significantly benefiting hospital operations.

Innovative Breast Milk Condensing Technology

BBy's main product is a condensing device that transforms breast milk into a fine powder form, retaining its essential biological and immunological properties. The process removes the need for freezing and defrosting, which is typically necessary for milk preparation in hospitals. This technology ensures the milk remains effective for up to 6 months. This innovative device, known by the codename Krrish, spares the biome completely, making it a unique solution in the field.

Peer-Reviewed and Hospital-Approved

BBy's technology has undergone peer review and has been published in scientific journals. Their breast milk condensing device is utilized in over 20 hospitals across the New York Tri-State area. The adoption by hospitals underscores the trust in its efficacy and its crucial role in improving infant nutrition and care.

Enhanced Testing Standards

BBy has enhanced testing standards that now include COVID-19 and pasteurization protocols. This ensures that their processes can denature and remove COVID-19 from breast milk, providing an additional layer of safety. This comprehensive approach highlights BBy’s commitment to meeting the highest safety and quality standards in the healthcare industry.

Report inaccurate information

Companies similar to BBy

Anja Health, based in Los Angeles, CA, provides stem cell banking services for pregnant parents, focusing on affordability and efficiency with a significant online presence.

NearWave, based in Austin, TX, and South Bend, IN, develops a handheld imaging device for breast cancer therapy selection, aiming to minimize patient suffering from ineffective treatments.

Brown Foods, based in Boston, MA, is a healthcare company in the industrial bio sub-industry, developing UnReal Milk, a lab-based dairy alternative aimed at disrupting the conventional dairy market.

Ananya Health, based in San Francisco, is developing a portable cryoablation medical device aimed at making cervical cancer treatment accessible worldwide at reduced costs.

Persist AI, based in Woodland, CA, specializes in using AI-driven automation to halve the development time for long-lasting drug injections, focusing on chronic diseases such as cancer and diabetes.

Modoo Technology, based in Beijing, develops wearable fetal health monitors for the pregnancy market, featuring devices that track baby's heart rate and movements and connect to apps for data sharing.

Nobell Foods, formerly known as Alpine Roads, is a San Francisco-based company specializing in creating cheese and other dairy products from plant-derived proteins, targeting consumers in the USA and Canada who prioritize taste and affordability.

Cowlar, based in Memphis, TN, developed a wearable device for dairy cows to monitor health and optimize dairy production, offering actionable recommendations to farmers. The company, which participated in Y Combinator's W17 batch, is currently inactive.

UE LifeSciences develops innovative cancer screening technologies, including the iBreastExam and cervAIcal devices, and has recently introduced Selfi, an at-home breast health monitoring platform.

Wildflower Health provides virtual and in-person lactation support services, integrating digital tools and human touch to offer personalized experiences. The company supports providers, payers, and families with a clinically-integrated solution and has received multiple awards for its value-based maternity care initiatives.